• CELMoDs: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways

  • Jul 11 2024
  • Duración: 24 m
  • Podcast

CELMoDs: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this podcast episode, Julio C. Chavez, MD, MS, and Alan Skarbnik, MD, discuss the emerging role of CELMoDs in NHL care, including:

    • Rationale for targeting CELMoDs in NHL
    • Mechanism of action of CELMoDs
    • Key studies and available efficacy and safety data with investigational CELMoDs in NHL
    • Key ongoing clinical trials of CELMoDs in NHL
    • Strategies to boost NHL clinical trial diversity among underserved communities

    Presenters:

    Julio C. Chavez, MD, MS
    Associate Member
    Department of Malignant Hematology
    ICE-T Clinical Research Medical Director for Hematologic Malignancies
    H. Lee Moffitt Cancer Center and Research Institute
    Associate Professor
    University of South Florida
    Tampa, Florida

    Alan Skarbnik, MD
    Director, Lymphoma and CLL Program
    Director, Immune Effector Cell Therapeutics Program
    Novant Health Cancer Institute
    Charlotte, North Carolina

    Content based on an online CME program supported by educational grants from Bristol-Myers Squibb.

    Link to full program:
    https://bit.ly/45YXoZI
    Más Menos
activate_WEBCRO358_DT_T2
Educación Enfermedades Físicas Hygiene & Healthy Living Ciencias Biológicas
Más Menos

Lo que los oyentes dicen sobre CELMoDs: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles